Table 4.

Clinicopathological characteristics of BC patients group (n = 80).

	BC patients group (n = 80)
Age
Mean ± SD	57.6 ± 9.3 years
Range	(44–77) years
Histological grade
II	64 (80%)
III	16 (20%)
Clinical stage
II	48 (60%)
III	32 (40%)
Tumor size
≤ 5	54 (67.5%)
< 5	26 (32.5%)
Axillary lymph node involvement
Positive	50 (62.5%)
Negative	30 (37.5%)
ER status
Positive	76 (95%)
Negative	4 (5%)
PR status
Positive	76 (95%)
Negative	4 (5%)
Her-2/neu expression
Positive	32 (40%)
Negative	48 (60%)
Vascular invasion
Positive	80 (100%)
Negative	0 (0%)

ER estrogen receptor status, PR progesterone receptor status, Her-2 human epidermal growth factor receptor 2.